|
Real-time Estimate
Cboe BZX
07:46:16 29/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.695 USD | +0.19% |
|
-4.58% | +50.56% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.21x | - | -0.03x | - | - | - | - | 22Cr | |
| 33.68x | 21.4x | 0.63x | 12.2x | 24.79x | 26.23x | 0.59% | 1,05600Cr | |
| 30.25x | - | -1.64x | 6.73x | 18.83x | 21.16x | 1.97% | 66TCr | |
| 33.7x | -484.91x | 0.14x | 7.87x | 16.27x | 16.96x | 2.61% | 47TCr | |
| 19.34x | 7.07x | 1.33x | 4.71x | 11.68x | 12.95x | 2.82% | 34TCr | |
| 20.6x | 5.86x | -11.89x | 5.35x | 13.29x | 14.17x | 2.98% | 28TCr | |
| 21.11x | 4.76x | 1.06x | 4.38x | 12.46x | 13.11x | 2.02% | 26TCr | |
| 26.41x | 19.98x | 2.34x | 6.87x | 12.24x | 15.77x | 2.41% | 23TCr | |
| -46.04x | 11.33x | 0.31x | 6.69x | 26.14x | 63.43x | 2.16% | 19TCr | |
| 11.29x | 4.76x | -3.76x | 4.12x | 8.55x | 10.02x | 4.45% | 17TCr | |
| 18.11x | 1.87x | 1.09x | 3.39x | 8.69x | 9.88x | 5.99% | 16TCr | |
| 54.23x | 8.56x | -1.49x | 9.68x | 33.18x | 26.7x | -.--% | 13TCr | |
| 11.38x | 5.36x | 0.18x | 3.19x | 8.31x | 8.95x | 3.96% | 13TCr | |
| 14.43x | 4.6x | -1.66x | 2.82x | 8.35x | 9.29x | 3.74% | 9.88TCr | |
| 11.47x | 1.17x | -6.07x | 2.05x | 6.64x | 7.34x | 5.91% | 9.81TCr | |
| 20.75x | 4.67x | 1.28x | 6.91x | 13.13x | 13.82x | 2.12% | 6.65TCr | |
| 46.95x | 1.27x | 13.32x | 2.84x | 10.42x | 28.45x | 3.45% | 6.02TCr | |
| 23.04x | 1.77x | -0.14x | 1.74x | 8.23x | 14.11x | 0.32% | 5.67TCr | |
| 31.94x | 4.31x | 1.77x | 7.43x | 25.18x | 28.16x | 0.55% | 4.36TCr | |
| Average | 20.73x | -22.13x | -0.17x | 5.50x | 14.80x | 18.92x | 2.67% | 23.66TCr | |
| Weighted average by Cap. | 24.33x | -49.35x | -0.61x | 7.24x | 17.29x | 20.28x | 2.22% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
